S Yang1, G Lin, L Deng, G-X Lu. 1. National Engineering Research Center of Human Stem Cells, Key Laboratory of Reproduction and Stem Cell, Ministry of Health, Institute of Reproductive and Stem Cell Engineering, Central South University, Changsha, China.
Abstract
OBJECTIVES: The objective of this study was to compare tumourigenic characteristics of human embryonic stem cells (HESCs) and embryonal carcinoma cells (ECCs) to identify a robust and simple model for studying certain aspects of cell transformation and tumourigenesis, in tumour progression of HESCs. MATERIALS AND METHODS: SSEA-3 positive ECCs (NTERA-2) cells were identified and compared to HESCs (ch HES-20) in terms of pluripotency and differentiation capacity, growth characteristics, gene expression profiles and signalling pathways. RESULTS: Our results showed that NTERA-2 cells shared similarities in expression markers of pluripotency to ch HES-20 cells. However, NTERA-2 cells also expressed some markers of differentiation and had a tendency to differentiate towards ectodermal endpoints. We identified NTERA-2 cells with higher S-phase fraction in cell cycle distribution, anti-apoptosis markers and robust self-renewal ability, compared to ch HES-20 cells. Microarray analysis and real-time PCR results showed that some oncogenes were up-regulated and tumour-suppression genes were down-regulated, whereas pluripotency-related genes were up-regulated and differentiation-related genes were down-regulated, and that Wnt and Notch signalling pathways were activated during progression from ES cells to EC cells. CONCLUSION: Tumourigenic characteristics of ECCs may provide a valuable insight into possible tumour progression of HESCs.
OBJECTIVES: The objective of this study was to compare tumourigenic characteristics of human embryonic stem cells (HESCs) and embryonal carcinoma cells (ECCs) to identify a robust and simple model for studying certain aspects of cell transformation and tumourigenesis, in tumour progression of HESCs. MATERIALS AND METHODS: SSEA-3 positive ECCs (NTERA-2) cells were identified and compared to HESCs (ch HES-20) in terms of pluripotency and differentiation capacity, growth characteristics, gene expression profiles and signalling pathways. RESULTS: Our results showed that NTERA-2 cells shared similarities in expression markers of pluripotency to ch HES-20 cells. However, NTERA-2 cells also expressed some markers of differentiation and had a tendency to differentiate towards ectodermal endpoints. We identified NTERA-2 cells with higher S-phase fraction in cell cycle distribution, anti-apoptosis markers and robust self-renewal ability, compared to ch HES-20 cells. Microarray analysis and real-time PCR results showed that some oncogenes were up-regulated and tumour-suppression genes were down-regulated, whereas pluripotency-related genes were up-regulated and differentiation-related genes were down-regulated, and that Wnt and Notch signalling pathways were activated during progression from ES cells to EC cells. CONCLUSION: Tumourigenic characteristics of ECCs may provide a valuable insight into possible tumour progression of HESCs.
Authors: Nimet Maherali; Rupa Sridharan; Wei Xie; Jochen Utikal; Sarah Eminli; Katrin Arnold; Matthias Stadtfeld; Robin Yachechko; Jason Tchieu; Rudolf Jaenisch; Kathrin Plath; Konrad Hochedlinger Journal: Cell Stem Cell Date: 2007-06-07 Impact factor: 24.633
Authors: P W Andrews; J Casper; I Damjanov; M Duggan-Keen; A Giwercman; J Hata; A von Keitz; L H Looijenga; J L Millán; J W Oosterhuis; M Pera; M Sawada; H J Schmoll; N E Skakkebaek; W van Putten; P Stern Journal: Int J Cancer Date: 1996-06-11 Impact factor: 7.396
Authors: Kristian Almstrup; Si Brask Sonne; Christina E Hoei-Hansen; Anne Marie Ottesen; John E Nielsen; Niels E Skakkebaek; Henrik Leffers; Ewa Rajpert-De Meyts Journal: Int J Androl Date: 2006-02
Authors: Martin A Rijlaarsdam; David M J Tax; Ad J M Gillis; Lambert C J Dorssers; Devin C Koestler; Jeroen de Ridder; Leendert H J Looijenga Journal: PLoS One Date: 2015-04-10 Impact factor: 3.240
Authors: Ronak Eini; Hans Stoop; Ad J M Gillis; Katharina Biermann; Lambert C J Dorssers; Leendert H J Looijenga Journal: PLoS One Date: 2014-01-03 Impact factor: 3.240
Authors: Sebastian F Vencken; Praveen Sethupathy; Gordon Blackshields; Cathy Spillane; Salah Elbaruni; Orla Sheils; Michael F Gallagher; John J O'Leary Journal: BMC Genomics Date: 2014-08-25 Impact factor: 3.969